nContact Surgical, Inc. Raises $7.5M Series B For Trials

NContact Surgical Inc., a surgical device company, has raised $7.5 million in Series B financing to finance clinical trials of its tissue coagulation devices, after which it hopes to gain U.S. regulatory approval.

>>> Discuss This Story